肺癌患者新辅助化疗期间出现肝脏肿物11例诊治体会
摘要
肺癌是目前世界上发病率和病死率最高的恶性肿瘤,且其发病率和病死率仍有上升趋势[1]。手术是目前治疗肺癌的首选方法,但早期肺癌很少有明显的症状,大多数发现时已是进展期,失去了手术治疗的机会。近些年来,术前新辅助化疗让一部分原本失去手术机会的肺癌患者可以进行手术治疗。我们在对肺癌患者进行术前新辅助化疗期间(2011年3月~2014年2月)11例出现肝脏肿物,现结合临床资料将诊治体会总结如下。
出处
《山东医药》
CAS
北大核心
2015年第23期103-105,共3页
Shandong Medical Journal
参考文献8
-
1Jemal A, Bray F, Center MM, et al. Global cancer statistics[ J]. CA Cancer J Clin, 2011,61 (2) :69-90.
-
2郑庆锋,王宇昭,朱赛楠,刘毅强,李少雷,吴楠,陈晋峰,张力建,杨跃.新辅助化疗及辅助化疗相关循证医学证据的应用对NSCLC治疗的影响[J].中国肿瘤临床,2011,38(4):232-234. 被引量:10
-
3Song WA, Zhou NK, Wang W, et al. Survival benefit of neoadju- vant chemotherapy in non-small cell lung cancer: an update recta- analysis of 13 randomized control trial [ J ]. J Thbrac Oncol, 2010, 5(4) :510-516.
-
4Kim YK, Park G, Kim cS, et al. Diagnostic efficacy of gadoxetic acid-enhanced MRI for the detection and cbaracterisation of liver metastases: comparison with multidetector-row CT[ J]. Br J Radi- ol, 2012,85 (1013) :539-547.
-
5Sacks A, Pellet PJ, Surasi DS, et al. Value of PET/CT in the management of liver metastases, part 1 [ J . A JR Am J Roentgen- ol, 2011,197(2) :256-259.
-
6Szymezak A, Simon K, Inglot M, et al. Safety and effectiveness of blind percutaneous liver biopsy : analysis of 1412 procedures [ J ]. Hepat Mon, 2012,12( 1 ) :32-37.
-
7Morris E J, Forman D, Thomas JD, et al. Surgical management and outcomes of colorectal cancer liver metastases [ J ]. Br J Surg, 2010,97(7) :1110-1118.
-
8Ileana E, Greillier L, Moutardier V, et al. Surgical resection of liver non-small cell lung cancer metastasis: a dual weapon [ J ]. Lung Cancer, 2010,70(2) :221-222.
二级参考文献10
-
1彭忠民,王潍博,罗静,陈景寒.新辅助化疗对Ⅲ期非小细胞肺癌细胞凋亡和增殖的影响[J].中国肿瘤临床,2005,32(14):798-800. 被引量:4
-
2Roth JA,Fossella F,Komaki R,et al.A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage Ⅲ A non-small-cell lung cancer[J].J Natl Cancer Inst,1994,86(9):673-680.
-
3Rosell R,Gomez-Codina J,Camps C,et al.A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer[J].N Engl J Med,1994,330(3):153-158.
-
4Depierre A,Milleron B,Moro-Sibilot D,et al.Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0),Ⅱ,and Ⅲ a non-small-cell lung cancer[J].J Clin Oncol,2002,20(1):247-253.
-
5Felip E,Rosell R,Maestre J,et al.Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer[J].J Clin Oncol,2010,28(19):3138-3145.
-
6Song WA,Zhou NK,Wang W,et al.Survival benefit of neoadjuvant chemotherapy in non-small cell lung cancer:an updated meta-analysis of 13 randomized control trials[J].J Thorac Oncol,2010,5(4):510-516.
-
7Scagliotti GV,Fossati R,Torri V,et al.Randomized study of adjuvant chemotherapy for completely resected stage Ⅰ,Ⅲ,or Ⅲ A non-small-cell lung cancer[J].Natl Cancer Inst,2003,95(19):1453-1461.
-
8Arriagada R,Bergman B,Dunant A,et al.Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer[J].New England Journal of Medicine,2004,350:351-360.
-
9Hotta K,Matsuo K,Ueoka H,et al.Role of adjuvantchemotherapy in patients with resected non-small-cell lung cancer:reappraisal with a meta-analysis of randomized controlled trails[J].J Clin Oncol,2004,22(19):3860-3867.
-
10Pignon JP,Tribodet H,Scagliotti GV,et al.Lung adjuvant cisplatin evaluation:a pooled analysis by the LACE collaborative group[J].J Clin Oncol,2008,26(21):3552-3559.
共引文献9
-
1阚红莉,孙红,关键,李明,周建英,庄莹莹,麻海春.术前新辅助化疗治疗肺癌的副作用及手术麻醉管理进展[J].中国当代医药,2013,20(1):29-31. 被引量:6
-
2郭添胜,韩靖,陈成坚.血管内皮生长因子在NSCLC卡铂联合紫杉醇化疗中检测的临床价值研究[J].河北医学,2013,19(7):1057-1059. 被引量:1
-
3莫绍雄,杨小平,吴军,韦懿桐.根治术结合^(125)I粒子植入治疗非小细胞肺癌53例分析[J].重庆医学,2013,42(23):2819-2821. 被引量:2
-
4杨金坡,王启鸣,马智勇.新辅助化疗对NSCLC预后影响的Meta分析[J].中国实用医刊,2014,41(10):6-13. 被引量:2
-
5颜华.沙利度胺联合吉非替尼新辅助化疗对非小细胞肺癌疗效研究[J].中国实用医刊,2015,42(15):92-94. 被引量:4
-
6唐金明,李旭,谢李,袁运长.ⅢA(N2)期非小细胞肺癌的诊疗进展[J].医学临床研究,2015,32(12):2414-2422. 被引量:7
-
7唐富玉.沙利度胺联合吉非替尼新辅助化疗在非小细胞肺癌患者中应用研究[J].中国现代药物应用,2016,10(4):110-111. 被引量:3
-
8徐晓鸿,陈家斌,夏银稳,阮君山.沙利度胺联合吉非替尼新辅助化疗对非小细胞肺癌的临床价值[J].昆明医科大学学报,2016,37(1):65-68. 被引量:22
-
9王胜,开金丹,徐元涛,熊飞.新辅助化疗对非小细胞肺癌行完全性切除术患者生存期的影响[J].武汉大学学报(医学版),2016,37(5):797-800. 被引量:4
-
1白学章,华声,白华.超声引导下肝脏肿物穿刺诊断的体会[J].河南肿瘤学杂志,2003,16(3):170-170. 被引量:1
-
2齐丽英,梁先兰,冯丽华,李庆林,秦怡,王存义.超声引导下肝脏肿物穿刺活检的临床价值[J].实用医技杂志,2012,19(9):924-925.
-
3阚秀,邢香芬,李吉友,董宝伟,陈敏华.肝脏肿物超声引导经皮细针吸取细胞学与组织学检查对照研究[J].中国肿瘤临床,1992,19(4):261-264. 被引量:3
-
4徐明月,李金龙,曲强,卢芳,史海达,史宪杰.恶性嗜铬细胞瘤肝内多发转移一例分析[J].国际外科学杂志,2016,43(4):255-256.
-
5刘江涛.漫谈肝血管瘤[J].健康促进,2011(1):15-16.
-
6主理群,于桂兰.2例老年非肿瘤患者血清糖原抗原19-9水平明显升高[J].基础医学与临床,2011,31(4):447-449.
-
7刘江涛,小徐.肝血管瘤漫谈[J].中老年保健,2010(10):20-21.
-
8梁杰.肾上腺肿物误诊为肝血管瘤一例[J].中国医疗前沿(学术版),2008,3(2). 被引量:1
-
9张昊,孙莉.肝癌术后多器官功能衰竭治愈一例[J].麻醉与监护论坛,2008,15(5):337-338.
-
10关丽莉,王寅,关伟华,任银.超声引导经皮肝占位性病变穿刺术的护理[J].临床医药实践,2005,14(12):947-947.